Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial.

Authors :: Ensam B
Scrocco C
Johnson D
Wijeyeratne YD
Bastiaenen R
Gray B
Miles C
Ben-Haim Y
Papatheodorou S
Sharma S
Papadakis M
Devine B
Macfarlane PW
Behr ER
Source :: Circulation [Circulation] 2024 May 21; Vol. 149 (21), pp. 1693-1695. Date of Electronic Publication: 2024 May 20.
Publication Year :: 2024
Abstract: Competing Interests: Disclosures None.

Subjects :: Humans
Male
Adult
Female
Anti-Arrhythmia Agents therapeutic use
Anti-Arrhythmia Agents adverse effects
Anti-Arrhythmia Agents pharmacology
Middle Aged
Healthy Volunteers
Brugada Syndrome physiopathology
Ajmaline pharmacology
Ajmaline therapeutic use
Electrocardiography drug effects

Full Text Access

Tools